Unituxin (United Therapeutics Corp.)
Welcome to the PulseAid listing for the Unituxin drug offered from United Therapeutics Corp.. This Glycolipid Disialoganglioside-directed Antibody [EPC],Glycolipid Disialoganglioside-directed Antibody Interactions [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | United Therapeutics Corp. |
| NON-PROPRIETARY NAME: | DINUTUXIMAB |
| SUBSTANCE NAME: | DINUTUXIMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glycolipid Disialoganglioside-directed Antibody [EPC],Glycolipid Disialoganglioside-directed Antibody Interactions [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-03-10 |
| END MARKETING DATE: | 0000-00-00 |
Unituxin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Unituxin from United Therapeutics Corp. |
| LABELER NAME: | United Therapeutics Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3.5(mg/mL) |
| START MARKETING DATE: | 2015-03-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66302-014_d4486144-cf2c-4dcf-8d82-4800ada91d2b |
| PRODUCT NDC: | 66302-014 |
| APPLICATION NUMBER: | BLA125516 |
Other DINUTUXIMAB Pharmaceutical Manufacturers / Labelers:
